Showing results (191-200 of 216) with videos related to
Sort By:
Pageof 22
Molecular Pharmacology|August 30, 2012
Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulinFrancis S Willard, Denise Wootten, Aaron D Showalter, et al.Journal of Medicinal Chemistry|March 26, 1998
Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factorsG W Rewcastle, D K Murray, W L Elliott, et al.Blood|March 28, 2015
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignanciesLuke F Peterson, Hanshi Sun, Yihong Liu, et al.Journal of Medicinal Chemistry|July 21, 2001
Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptorJ B Smaill, H D Showalter, H Zhou, et al.Molecular & Cellular Proteomics : MCP|July 22, 2014
Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cellsMing Zhang, Mélanie Robitaille, Aaron D Showalter, et al.Structure (London, England : 1993)|April 9, 2019
Altered Domain Structure of the Prion Protein Caused by Cu2+ Binding and Functionally Relevant Mutations: Analysis by Cross-Linking, MS/MS, and NMRAlex J McDonald, Deborah R Leon, Kathleen A Markham, et al.Diabetes|September 9, 2010
Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human isletsKyle W Sloop, Francis S Willard, Martin B Brenner, et al.Proceedings of the National Academy of Sciences of the United States of America|November 12, 2020
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonistTakahiro Kawai, Bingfa Sun, Hitoshi Yoshino, et al.Bioorganic & Medicinal Chemistry|January 25, 2014
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I)Zhenghong Peng, David S Maxwell, Duoli Sun, et al.The Journal of Biological Chemistry|May 5, 2007
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage diseaseKyle W Sloop, Aaron D Showalter, Amy L Cox, et al.Pageof 22